- Trials with a EudraCT protocol (49)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
49 result(s) found for: Inferior Myocardial Infarction.
Displaying page 1 of 3.
EudraCT Number: 2008-005140-16 | Sponsor Protocol Number: KAI-9803-004 | Start Date*: 2009-06-02 | |||||||||||
Sponsor Name:KAI Pharmaceuticals, Inc | |||||||||||||
Full Title: Inhibition of δ-PROTEin kinase C for the reducTION of infarct size in Acute Myocardial Infarction (PROTECTION AMI) | |||||||||||||
Medical condition: Acute Myocardial Infarction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) DE (Completed) ES (Completed) HU (Completed) CZ (Completed) PT (Completed) BE (Completed) SE (Completed) FI (Completed) IT (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001437-27 | Sponsor Protocol Number: P150801 | Start Date*: 2016-12-30 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Efficacy of furosemide versus vascular filling in Patients with Acute Myocardial Infarction with Right Ventricular Extension: a multicentric randomized controlled trial. | |||||||||||||
Medical condition: Myocardial infarction with right ventricular extension. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000142-20 | Sponsor Protocol Number: 2003056 | Start Date*: 2004-10-01 | |||||||||||
Sponsor Name:Procter & Gamble Pharmaceuticals | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of Pexelizumab in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention | |||||||||||||
Medical condition: Following as ST-wave elevation myocardial infarction, there is local ischemia. When reperfusion occurs, there is a complement mediated inflammatory reponse, known as reperfusion injury, and a syst... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) AT (Prematurely Ended) SE (Prematurely Ended) ES (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011485-28 | Sponsor Protocol Number: MANAMI101-09 | Start Date*: 2009-08-12 |
Sponsor Name:PledPharma AB | ||
Full Title: A local feasibility study of mangafodipir as an adjunct to percutaneous coronary intervention in patients with acute myocardial infarction | ||
Medical condition: Patients with acute myocardial infarction decided for treatment by percutaneous coronary intervention (PCI) are included. The test drug mangafodipir is administered intravenously just prior to PCI.... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-015712-17 | Sponsor Protocol Number: G080186 | Start Date*: 2010-03-25 | |||||||||||
Sponsor Name:HCRI | |||||||||||||
Full Title: A prospective, multi-center, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy (DAPT) in subjects undergoing percutaneous cor... | |||||||||||||
Medical condition: Dual antiplatelet therapy (DAPT) in subjects undergoing percutaneous coronary intervention (PCI) with either drug eluting stent (DES) or bara metal stent (BMS) placement for the treatment of corona... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) HU (Completed) DE (Completed) CZ (Completed) GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001883-31 | Sponsor Protocol Number: CARMRUSMIAMBULANCE20190823 | Start Date*: 2020-02-25 |
Sponsor Name:VU Univesity Medical Center (VUmc) | ||
Full Title: Microvascular Recovery using contrast Ultrasound in ST-elevation Myocardial Infarction in the ambulance (MRUSMI-Ambulance) | ||
Medical condition: ST elevation myocardial infarction | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-001219-44 | Sponsor Protocol Number: 1123.28 | Start Date*: 2008-01-30 | |||||||||||
Sponsor Name:Boehringer Ingelheim France | |||||||||||||
Full Title: STREAM - STrategic Reperfusion Early After Myocardial Infarction Comparison of the efficacy and safety of a strategy of pre-hospital fibrinolytic treatment with tenecteplase and additional antipla... | |||||||||||||
Medical condition: ST-elevation myocardial infaction within 3 hours of onset of symptoms | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) AT (Completed) GB (Completed) IT (Completed) ES (Completed) BE (Completed) DE (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002876-18 | Sponsor Protocol Number: 2011-002876-18 | Start Date*: 2011-12-19 | |||||||||||
Sponsor Name:IST. DI RICERCHE FARMACOLOG. M. NEGRI | |||||||||||||
Full Title: CYCLosporinE A in reperfused acute myocardial infarction (CYCLE-Trial) | |||||||||||||
Medical condition: All (male and female) patients, aged over 18, presenting with a large STEMI not older than 4 hours (defined as angina pectoris or equivalent symptoms of more than 30 minutes duration within the las... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005933-34 | Sponsor Protocol Number: SFHI01 | Start Date*: 2021-08-09 | |||||||||||
Sponsor Name:Sorin CRM SAS (Microport CRM) | |||||||||||||
Full Title: Evaluation of a modified Anti-Platelet Therapy associated with low-dose rapamycin DES Firehawk in Acute Myocardial Infarction Patients treated with complete revascularization strategy | |||||||||||||
Medical condition: Patients with clinically stable, low to moderate complexity acute Myocardial Infarction (MI; troponine-positive Non-ST-Elevation MI or ST-Elevation MI) requiring primary Percutaneous Coronary Inte... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Ongoing) NL (Ongoing) ES (Ongoing) IT (Ongoing) PT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001642-26 | Sponsor Protocol Number: LRD.2016.STREAM2 | Start Date*: 2017-10-02 | |||||||||||
Sponsor Name:Leuven Research & Development (LRD) at University of Leuven, Belgium | |||||||||||||
Full Title: STREAM-2 (STrategic Reperfusion in elderly patients Early After Myocardial Infarction) | |||||||||||||
Medical condition: ST-elevation myocardial infarction within 3 hours of onset of symptoms | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001514-41 | Sponsor Protocol Number: G040188 | Start Date*: 2005-07-06 |
Sponsor Name:The Cardiovascular Research Foundation | ||
Full Title: A dual arm factorial randomized trial in patients with ST segment elevation AMI to compare the results of using either anticoagulation with unfractionated heparin plus routine GP IIb/IIIa inhibitio... | ||
Medical condition: The medical condition for this clinical trial is Acute Myocardial Infarction (AMI). AMI is defined as death or necrosis of myocardial cells. It is a diagnosis at the end of the spectrum of myocardi... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) SE (Prematurely Ended) ES (Completed) DE (Completed) GB (Completed) DK (Temporarily Halted) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000539-29 | Sponsor Protocol Number: 2018.02.08 | Start Date*: 2018-12-11 | |||||||||||||||||||||
Sponsor Name:Hamilton Health Sciences Corporation | |||||||||||||||||||||||
Full Title: PeriOperative ISchemic Evaluation-3 (POISE-3) Trial | |||||||||||||||||||||||
Medical condition: The occurrence of life-threatening, major, and critical organ bleeding, and, major arterial and venous thrombosis in patients undergoing noncardiac surgery. And for patients in the blood pressure m... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: BE (Ongoing) DK (Completed) AT (Completed) NL (Ongoing) IT (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000313-38 | Sponsor Protocol Number: EFC5965 | Start Date*: 2007-01-24 | |||||||||||
Sponsor Name:Sanofi-aventis Recherche & Développement | |||||||||||||
Full Title: Randomized, multinational, double-blind study, comparing a high loading dose regimen of clopidogrel versus standard dose in patients with unstable angina or myocardial infarction managed with an ea... | |||||||||||||
Medical condition: Patients with non-ST segment elevation myocardial infarction managed with an early PCI. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) CZ (Completed) FI (Completed) IE (Completed) SK (Completed) FR (Completed) SE (Completed) DE (Completed) AT (Completed) EE (Completed) BG (Completed) GR (Completed) IT (Completed) GB (Completed) LT (Completed) NL (Completed) LV (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002518-11 | Sponsor Protocol Number: 8835-004 | Start Date*: 2014-01-16 | |||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS CARDIOVASCULAR OUTCOMES FOLLOWING TREATMENT WITH ERTUGLIFLOZIN (MK-8835/PF-04971729) IN SUBJECTS WITH TYPE 2 DIABETES ME... | |||||||||||||
Medical condition: Type 2 Diabetes Mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) NL (Completed) GB (Completed) IT (Completed) ES (Completed) BG (Completed) PL (Completed) GR (Completed) HR (Completed) SK (Completed) LT (Completed) LV (Completed) CZ (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003700-10 | Sponsor Protocol Number: CL3-18886-012 | Start Date*: 2006-01-27 | |||||||||||
Sponsor Name:Institut de Recherches Internationales Servier | |||||||||||||
Full Title: Prevention of cerebrovascular and cardiovascular Events of ischaemic origin with teRutroban in patients with a history oF ischaemic strOke or tRansient ischaeMic attack. The PERFORM Study. An inter... | |||||||||||||
Medical condition: Ischaemic stroke or transient ischaemic attack | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) AT (Prematurely Ended) FI (Completed) ES (Completed) GB (Completed) SE (Prematurely Ended) HU (Completed) CZ (Prematurely Ended) SI (Prematurely Ended) LT (Prematurely Ended) IT (Prematurely Ended) PT (Prematurely Ended) SK (Completed) DE (Completed) IE (Prematurely Ended) GR (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-016812-18 | Sponsor Protocol Number: AN-CVD2233 | Start Date*: 2011-02-10 | |||||||||||
Sponsor Name:Anthera Pharmaceuticals, Inc. | |||||||||||||
Full Title: Evaluation of the Safety and Efficacy of Short-term A-002 Treatment in Subjects with Acute Coronary Syndromes | |||||||||||||
Medical condition: Treatment of patients with Acute Coronary Syndromes (ACS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) ES (Completed) HU (Prematurely Ended) IT (Prematurely Ended) CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001481-14 | Sponsor Protocol Number: TAX-001 | Start Date*: 2005-06-22 |
Sponsor Name:University Hospital Tübingen | ||
Full Title: LOCAL-TAX Trial: Local intracoronary administration of Paclitaxel after stent implantation for prevention of restenosis in comparison with stent implantation alone and with implantation of a Paclit... | ||
Medical condition: coronary heart disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-024667-40 | Sponsor Protocol Number: PGxSTEMI08 | Start Date*: 2019-04-23 |
Sponsor Name:St. Antonius Hospital | ||
Full Title: Cost-effectiveness of CYP2C19 guided treatment with antiplatelet drugs in patients with ST-segment-elevation myocardial infarction undergoing immediate percutaneous coronary intervention with stent... | ||
Medical condition: ST-segment myocardial infarction (STEMI) followed by immediate percutaneous coronary intervention with stent implantation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-002391-13 | Sponsor Protocol Number: PlinytheElder | Start Date*: 2021-01-08 | |||||||||||
Sponsor Name:AOU FEDERICO II | |||||||||||||
Full Title: Platelet inhibition with Ticagrelor 60 mg versus Ticagrelor 90 mg twice daily in elderly patients with acute coronary syndrome (ACS). | |||||||||||||
Medical condition: Acute coronary syndrome | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001922-26 | Sponsor Protocol Number: BMI-EU-02-008 | Start Date*: 2006-01-06 |
Sponsor Name:Bioheart, Inc | ||
Full Title: A Phase II, Open-label, Randomized, Multicenter Study to Assess the Safety and Cardiovascular Effects of MyoCell™ Implantation by a Catheter Delivery System in Congestive Heart Failure Patients Pos... | ||
Medical condition: Patients with congestive heart failure who have had a previous myocardial infarction. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) BE (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.